Growth Metrics

AtriCure (ATRC) Equity Average (2016 - 2025)

AtriCure (ATRC) has disclosed Equity Average for 15 consecutive years, with $484.2 million as the latest value for Q4 2025.

  • Quarterly Equity Average rose 4.58% to $484.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $484.2 million through Dec 2025, up 4.58% year-over-year, with the annual reading at $476.5 million for FY2025, 2.78% up from the prior year.
  • Equity Average for Q4 2025 was $484.2 million at AtriCure, up from $470.5 million in the prior quarter.
  • The five-year high for Equity Average was $486.1 million in Q4 2021, with the low at $388.2 million in Q2 2021.
  • Average Equity Average over 5 years is $455.7 million, with a median of $459.7 million recorded in 2022.
  • The sharpest move saw Equity Average skyrocketed 69.29% in 2021, then dropped 6.7% in 2022.
  • Over 5 years, Equity Average stood at $486.1 million in 2021, then fell by 6.7% to $453.5 million in 2022, then rose by 2.42% to $464.5 million in 2023, then fell by 0.32% to $463.0 million in 2024, then increased by 4.58% to $484.2 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $484.2 million, $470.5 million, and $459.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.